Cargando…

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

The key to battling the COVID-19 pandemic and its potential aftermath is to develop a variety of vaccines that are efficacious and safe, elicit lasting immunity, and cover a range of SARS-CoV-2 variants. Recombinant viral receptor-binding domains (RBDs) are safe vaccine candidates but often have lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Qibin, Tai, Wanbo, Baxter, Victoria K., Shi, Juan, Wan, Yushun, Zhang, Xiujuan, Montgomery, Stephanie A., Taft-Benz, Sharon A., Anderson, Elizabeth J., Knight, Audrey C., Dinnon, Kenneth H., Leist, Sarah R., Baric, Ralph S., Shang, Jian, Hong, Sung-Wook, Drelich, Aleksandra, Tseng, Chien-Te K., Jenkins, Marc, Heise, Mark, Du, Lanying, Li, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448314/ https://www.ncbi.nlm.nih.gov/pubmed/34492082 http://dx.doi.org/10.1371/journal.ppat.1009897

Ejemplares similares

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
por: Heise, Mark, et al.
Publicado: (2023)

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
por: Wan, Yushun, et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Advances in mRNA and other vaccines against MERS-CoV
por: Tai, Wanbo, et al.
Publicado: (2022)

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2
por: Ye, Gang, et al.
Publicado: (2020)

Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy
por: Tai, Wanbo, et al.
Publicado: (2019)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Adams, Lily E., et al.
Publicado: (2021)

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
por: Shi, Juan, et al.
Publicado: (2022)

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
por: Shi, Juan, et al.
Publicado: (2022)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold
por: Sun, Zehua, et al.
Publicado: (2020)

Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections
por: Leist, Sarah R., et al.
Publicado: (2018)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2016)

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2023)

The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation
por: George, Parakkal Jovvian, et al.
Publicado: (2020)

Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya Encephalomyelitis
por: Anderson, Elizabeth J., et al.
Publicado: (2023)

A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage
por: Gambino, Frank, et al.
Publicado: (2021)

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
por: Li, Wei, et al.
Publicado: (2020)

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Du, Lanying, et al.
Publicado: (2016)

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein
por: Wan, Yushun, et al.
Publicado: (2021)

Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice
por: Amruta, Narayanappa, et al.
Publicado: (2022)

SARS coronavirus and innate immunity
por: Frieman, Matthew, et al.
Publicado: (2008)

Host Genetics: It Is Not Just the Virus, Stupid
por: Ferris, Martin T., et al.
Publicado: (2016)

Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements
por: Snouwaert, John N., et al.
Publicado: (2023)

Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
por: Adams, Lily E., et al.
Publicado: (2023)

A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity
por: Gao, Yaning, et al.
Publicado: (2022)

Novel modulators of p53-signaling encoded by unknown genes of emerging viruses
por: Alzhanova, Dina, et al.
Publicado: (2021)

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
por: Wan, Yushun, et al.
Publicado: (2020)

Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine
por: Wang, Xinyi, et al.
Publicado: (2019)

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
por: Sun, Weina, et al.
Publicado: (2020)

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity
por: Dinnon III, Kenneth H., et al.
Publicado: (2019)

Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
por: Cockrell, Adam S., et al.
Publicado: (2018)

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
por: Gralinski, Lisa E., et al.
Publicado: (2018)

Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors
por: Gao, Yaning, et al.
Publicado: (2019)

Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis
por: Leist, Sarah R., et al.
Publicado: (2019)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
por: Ye, Gang, et al.
Publicado: (2021)

High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models
por: Li, Wei, et al.
Publicado: (2020)

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
por: Curreli, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_frfue0dcnbos7a65g46ai0jiu0